5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 11.83▲ | 11.61▲ | 11.54▲ | 11.50▲ | 10.23▲ |
MA10 | 11.73▲ | 11.44▲ | 11.45▲ | 11.25▲ | 10.01▲ |
MA20 | 11.58▲ | 11.41▲ | 11.36▲ | 10.30▲ | 12.96▼ |
MA50 | 11.48▲ | 11.31▲ | 11.28▲ | 10.10▲ | N/A |
MA100 | 11.38▲ | 11.31▲ | 10.59▲ | 13.36▼ | N/A |
MA200 | 11.32▲ | 10.40▲ | 10.02▲ | N/A | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.059▲ | 0.062▲ | 0.048▲ | 0.236▲ | 0.078▲ |
RSI | 67.410▲ | 66.226▲ | 66.456▲ | 62.488▲ | 44.293▼ |
STOCH | 66.199 | 81.542▲ | 56.944 | 57.933 | 44.109 |
WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -18.229▲ | -51.679 |
CCI | 193.721▲ | 262.364▲ | 245.914▲ | 114.528▲ | 1.823 |
Tuesday, April 22, 2025 04:00 AM
Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for ...
|
Monday, April 14, 2025 03:11 AM
On Tuesday, Rapport Therapeutics (NASDAQ: RAPP) received a new Buy rating from Stifel, with a price target set at $35.00. The... On Tuesday, Rapport Therapeutics' shares received a positive ...
|
Sunday, April 13, 2025 05:00 PM
Rapport Therapeutics’ competitors have higher revenue and earnings than Rapport Therapeutics. Rapport Therapeutics is trading at a higher price-to-earnings ratio than its competitors, indicating ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
02/05/25 | 12.08 | 12.15 | 11.955 | 12.15 | 2,096 |
01/05/25 | 11.57 | 11.75 | 10.99 | 11.47 | 119,800 |
30/04/25 | 10.84 | 11.74 | 10.81 | 11.45 | 94,932 |
29/04/25 | 11.17 | 11.54 | 11.01 | 11.055 | 59,291 |
28/04/25 | 10.81 | 12.20 | 10.705 | 11.38 | 394,031 |
25/04/25 | 10.96 | 11.31 | 10.45 | 10.62 | 70,924 |
24/04/25 | 11.34 | 11.65 | 10.78 | 11.10 | 77,800 |
23/04/25 | 11.84 | 12.85 | 11.33 | 11.38 | 174,881 |
22/04/25 | 10.30 | 11.89 | 10.30 | 11.55 | 136,300 |
21/04/25 | 9.98 | 10.645 | 9.81 | 10.38 | 118,700 |
|
|
||||
|
|
||||
|
|